Skip to content
Extreme Investor Network
  • Contact Us
  • Privacy Policy

Biopharma

JPMorgan’s Leading Biopharma Selections for 2025

February 20, 2025
JPMorgan's top biopharma picks for 2025

Biopharma Investing Insights: Top Picks from JPMorgan Welcome back to the Extreme Investor Network, where we dive deep into the intricate world of investing to provide you with the insights that matter. Today, we’re focusing … Read more

Categories Investing Tags Biopharma, JPMorgans, leading, selections

China’s Biopharma Sector Sees Increased Activity with Summit and Merck Partnerships

February 13, 2025
China biopharma deals rise with Summit, Merck

The Growing Influence of Chinese Biotech in the U.S. Pharma Landscape As the pharmaceutical landscape evolves, it becomes increasingly clear that the dynamic between American and Chinese biotechnology firms is shifting. At Extreme Investor Network, … Read more

Categories Business News Tags activity, Biopharma, Chinas, increased, Merck, partnerships, sector, sees, Summit

Arbutus Biopharma: The Pinnacle of Speculative Investments

January 13, 2025
Cramer's Lightning Round: Uber is a buy

Stock Performance Insights: What You Need to Know Welcome to the Extreme Investor Network, where we provide you with the most compelling insights into the stock market and investment opportunities. Today, we’re delving into the … Read more

Categories Mad Money Tags Arbutus, Biopharma, investments, Pinnacle, speculative

Categories

Recent Posts

  • JPMorgan’s Leading Biopharma Selections for 2025February 20, 2025
  • Average Credit Card Balance for Americans Reaches $6,580February 20, 2025
  • Kontoor Brands CEO Outlines Growth Strategies for Recent AcquisitionFebruary 20, 2025
  • Market Insights – February 20, 2025February 20, 2025
  • BitMEX to Introduce KAITOUSDT and PIUSDT Perpetual Swaps with 50x LeverageFebruary 20, 2025
  • Dow Drops 450 Points as S&P 500 Pulls Back from Record High Following Walmart’s Cautious ForecastFebruary 20, 2025
  • Japanese Yen and Australian Dollar Update: Will the BoJ Raise Rates Again? Key Focus on Inflation and PMIFebruary 20, 2025
  • Stocks with the Biggest After-Hours Moves: CELH, DBX, XYZFebruary 20, 2025
  • Rivian (RIVN) Q4 2024 Earnings ReportFebruary 20, 2025
  • Josh Brown: Palantir Trapped in ‘No-Man’s Land’ as Stock Momentum StallsFebruary 20, 2025

Archives

© 2025 Extreme Investor Network

Usermaven | Website analytics and product insights